Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Robert J Harris, Zena Willsmore, Roman Laddach, Silvia Crescioli, Jitesh Chauhan, Anthony Cheung, Anna Black, Jenny L. C. Geh, Alastair D MacKenzie Ross, Ciaran Healy, Sophia Tsoka, James Spicer, Katie E Lacy & Sophia N Karagiannis. (2022) Enriched circulating and tumor-resident TGF-β+ regulatory B cells in patients with melanoma promote FOXP3+ Tregs. OncoImmunology 11:1.
Read now
Read now
Zhiyuan Lin, Li Liu, Yu Xia, Xiang Chen, Ying Xiong, Yang Qu, Jiajun Wang, Qi Bai, Jianming Guo & Jiejie Xu. (2018) Tumor infiltrating CD19+ B lymphocytes predict prognostic and therapeutic benefits in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors. OncoImmunology 7:10, pages 1-9.
Read now
Read now
Articles from other publishers (41)
Qiuying Quan, Lingchuan Guo, Lili Huang, Zhiju Liu, Tianwei Guo, Yu Shen, Sisi Ding, Cuiping Liu & Lei Cao. (2023) Expression and clinical significance of PD-L1 and infiltrated immune cells in the gastric adenocarcinoma microenvironment. Medicine 102:48, pages e36323.
Crossref
Crossref
Yoon Ju Jung, Jin Seok Woo, Sun-Hee Hwang, SeungCheon Yang, So Jung Kim, JooYeon Jhun, Seung Yoon Lee, Kun Hee Lee, Mi-La Cho & Kyo Young Song. (2023) Effect of IL-10-producing B cells in peripheral blood and tumor tissue on gastric cancer. Cell Communication and Signaling 21:1.
Crossref
Crossref
Jiantong Bao, Annika C. Betzler, Jochen Hess & Cornelia Brunner. (2023) Exploring the dual role of B cells in solid tumors: implications for head and neck squamous cell carcinoma. Frontiers in Immunology 14.
Crossref
Crossref
Enkui Zhang, Chengsheng Ding, Shuchun Li, Xueliang Zhou, Batuer Aikemu, Xiaodong Fan, Jing Sun, Minhua Zheng & Xiao Yang. (2023) Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy. Biomarker Research 11:1.
Crossref
Crossref
Dan Pu, Dan Liu, Can Li, Chunyan Chen, Yuxin Che, Jiaoyan Lv, Yang Yang & Xuelian Wang. (2022) A novel ten-gene prognostic signature for cervical cancer based on CD79B-related immunomodulators. Frontiers in Genetics 13.
Crossref
Crossref
Ying Zhong, Xinyu Ren, Xi Cao, Yali Xu, Yu Song, Yidong Zhou, Feng Mao, Songjie Shen, Zhe Wang & Qiang Sun. (2022) Insulin-like growth factor 2 receptor is a key immune-related gene that is correlated with a poor prognosis in patients with triple-negative breast cancer: A bioinformatics analysis. Frontiers in Oncology 12.
Crossref
Crossref
Mahshid Shahverdi, Javad Masoumi, Farid Ghorbaninezhad, Neda Shajari, Farnaz Hajizadeh, Hamidreza Hassanian, Nazila Alizadeh, Mahdi Jafarlou & Behzad Baradaran. (2022) The modulatory role of dendritic cell-T cell cross-talk in breast cancer: Challenges and prospects. Advances in Medical Sciences 67:2, pages 353-363.
Crossref
Crossref
Kashif Rafiq Zahid, Umar Raza, Soumya Tumbath, Lingxiang Jiang, Wenjuan Xu & Xiumei Huang. (2022) Neutrophils: Musketeers against immunotherapy. Frontiers in Oncology 12.
Crossref
Crossref
X. Sun, T. Zhang, M. Li, L. Yin & J. Xue. (2022) Immunosuppressive B cells expressing PD-1/PD-L1 in solid tumors: a mini review. QJM: An International Journal of Medicine 115:8, pages 507-512.
Crossref
Crossref
Xuejiao Li, Huan Du, Shenghua Zhan, Wenting Liu, Zhangyu Wang, Jing Lan, Longxiang PuYang, Yuqiu Wan, Qiuxia Qu, Sining Wang, Yang Yang, Qin Wang & Fang Xie. (2022) The interaction between the soluble programmed death ligand-1 (sPD-L1) and PD-1+ regulator B cells mediates immunosuppression in triple-negative breast cancer. Frontiers in Immunology 13.
Crossref
Crossref
Fabian Flores-Borja & Paul Blair. (2022) Mechanisms of induction of regulatory B cells in the tumour microenvironment and their contribution to immunosuppression and pro-tumour responses. Clinical and Experimental Immunology 209:1, pages 33-45.
Crossref
Crossref
Céline M. Laumont, Allyson C. Banville, Mara Gilardi, Daniel P. Hollern & Brad H. Nelson. (2022) Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities. Nature Reviews Cancer 22:7, pages 414-430.
Crossref
Crossref
Yingqing Shi, Zhuogang Liu & Hongtao Wang. (2022) Expression of PD‐L1 on regulatory B cells in patients with acute myeloid leukaemia and its effect on prognosis. Journal of Cellular and Molecular Medicine 26:12, pages 3506-3512.
Crossref
Crossref
Justyna Sakowska, Łukasz Arcimowicz, Martyna Jankowiak, Ines Papak, Aleksandra Markiewicz, Katarzyna Dziubek, Małgorzata Kurkowiak, Sachin Kote, Karolina Kaźmierczak-Siedlecka, Karol Połom, Natalia Marek-Trzonkowska & Piotr Trzonkowski. (2022) Autoimmunity and Cancer—Two Sides of the Same Coin. Frontiers in Immunology 13.
Crossref
Crossref
Saife N. Lone, Ajaz A. Bhat, Nissar A. Wani, Thasni Karedath, Sheema Hashem, Sabah Nisar, Mayank Singh, Puneet Bagga, Bhudev Chandra Das, Davide Bedognetti, Ravinder Reddy, Michael P. Frenneaux, Wael El-Rifai, Mushtaq A. Siddiqi, Mohammad Haris & Muzafar A. Macha. (2022) miRNAs as novel immunoregulators in cancer. Seminars in Cell & Developmental Biology 124, pages 3-14.
Crossref
Crossref
Pooya Farhangnia & Mahzad Akbarpour. 2022. Encyclopedia of Infection and Immunity. Encyclopedia of Infection and Immunity
206
220
.
Sotirios G. Tsiogkas, Efthymios Dardiotis, Eirini I. Rigopoulou & Dimitrios P. Bogdanos. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
19
.
Chi Yan, Nabil Saleh, Jinming Yang, Caroline A. Nebhan, Anna E. Vilgelm, E. Premkumar Reddy, Joseph T. Roland, Douglas B. Johnson, Sheau-Chiann Chen, Rebecca L. Shattuck-Brandt, Gregory D. Ayers & Ann Richmond. (2021) Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade. Molecular Cancer 20:1.
Crossref
Crossref
Huan-Rong Lan, Wen-Lin Du, Yuyao Liu, Chun-Sen Mao, Ke-Tao Jin & Xue Yang. (2021) Role of immune regulatory cells in breast cancer: Foe or friend?. International Immunopharmacology 96, pages 107627.
Crossref
Crossref
Yuanming Jing, Fangming Xu, Wenqing Liang, Jian Liu & Lin Zhang. (2021) Role of regulatory B cells in gastric cancer: Latest evidence and therapeutics strategies. International Immunopharmacology 96, pages 107581.
Crossref
Crossref
M G Davey, É J Ryan, M S Davey, A J Lowery, N Miller & M J Kerin. (2021) Clinicopathological and prognostic significance of programmed cell death ligand 1 expression in patients diagnosed with breast cancer: meta-analysis. British Journal of Surgery 108:6, pages 622-631.
Crossref
Crossref
Vignesh Kamath. (2021) Cancer vaccines: An unkept promise?. Drug Discovery Today 26:6, pages 1347-1352.
Crossref
Crossref
Min Liu, Feng Wei, Jian Wang, Wenwen Yu, Meng Shen, Ting Liu, Dong Zhang, Yang Wang, Xiubao Ren & Qian Sun. (2021) Myeloid-derived suppressor cells regulate the immunosuppressive functions of PD-1−PD-L1+ Bregs through PD-L1/PI3K/AKT/NF-κB axis in breast cancer. Cell Death & Disease 12:5.
Crossref
Crossref
Jin Shang, Haoran Zha & Yufa Sun. (2020) Phenotypes, Functions, and Clinical Relevance of Regulatory B Cells in Cancer. Frontiers in Immunology 11.
Crossref
Crossref
Sahar Shariati, Fereshteh Mehdipour, Morteza Samadi, Reza Rasolmali, Abdol-Rasoul Talei & Abbas Ghaderi. (2020) The balance of regulatory and stimulatory B cell subsets in breast cancer draining lymph nodes correlates with tumor prognostic factors. Life Sciences 257, pages 118117.
Crossref
Crossref
Claire C. Baniel, Clinton M. Heinze, Anna Hoefges, Elizabeth G. Sumiec, Jaquelyn A. Hank, Peter M. Carlson, Won Jong Jin, Ravi B. Patel, Raghava N. Sriramaneni, Stephen D. Gillies, Amy K. Erbe, Ciara N. Schwarz, Alexander A. Pieper, Alexander L. Rakhmilevich, Paul M. Sondel & Zachary S. Morris. (2020) In situ Vaccine Plus Checkpoint Blockade Induces Memory Humoral Response. Frontiers in Immunology 11.
Crossref
Crossref
Jiyong Liang, Lulu Wang, Chao Wang, Jianfeng Shen, Bojin Su, Anantha L. Marisetty, Dexing Fang, Cynthia Kassab, Kang Jin Jeong, Wei Zhao, Yiling Lu, Abhinav K. Jain, Zhicheng Zhou, Han Liang, Shao-Cong Sun, Changming Lu, Zhi-Xiang Xu, Qinghua Yu, Shan Shao, XiaoHua Chen, Meng Gao, Francois X. Claret, Zhiyong Ding, Jian Chen, Pingsheng Chen, Michelle C. Barton, Guang Peng, Gordon B. Mills & Amy B. Heimberger. (2020) Verteporfin Inhibits PD-L1 through Autophagy and the STAT1–IRF1–TRIM28 Signaling Axis, Exerting Antitumor Efficacy. Cancer Immunology Research 8:7, pages 952-965.
Crossref
Crossref
Zhao Wang & Fei Tan. (2019)
The blockade of PD‐1/PD‐L1 pathway promotes the apoptosis of CD19
+
CD25
+
Bregs and suppresses the secretion of IL‐10 in patients with allergic rhinitis
. Scandinavian Journal of Immunology 91:2.
Crossref
Crossref
Anders Lindholm Sørensen, Mads Emil Bjørn, Caroline H. Riley, Morten Holmstrøm, Mads Hald Andersen, Inge Marie Svane, Stine Ulrik Mikkelsen, Vibe Skov, Lasse Kjær, Hans C. Hasselbalch & Claus H. Nielsen. (2019) B‐cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: Influence of ruxolitinib, interferon‐α2, or combination treatment. European Journal of Haematology 103:4, pages 351-361.
Crossref
Crossref
Min Liu, Qian Sun, Jian Wang, Feng Wei, Lili Yang & Xiubao Ren. (2018) A new perspective: Exploring future therapeutic strategies for cancer by understanding the dual role of B lymphocytes in tumor immunity. International Journal of Cancer 144:12, pages 2909-2917.
Crossref
Crossref
Olga S. Blomberg, Lorenzo Spagnuolo & Karin E. de Visser. (2018) Immune regulation of metastasis: mechanistic insights and therapeutic opportunities. Disease Models & Mechanisms 11:10.
Crossref
Crossref
B. Allard, S. Aspeslagh, S. Garaud, F.A. Dupont, C. Solinas, M. Kok, B. Routy, C. Sotiriou, J. Stagg & L. Buisseret. (2018) Immuno-oncology-101: overview of major concepts and translational perspectives. Seminars in Cancer Biology 52, pages 1-11.
Crossref
Crossref
P. J. Schuler, C. Brunner & T. K. Hoffmann. (2018) B-Zellen in der Kopf-Hals-OnkologieB cells in head and neck oncology. HNO 66:4, pages 296-300.
Crossref
Crossref
Meng Shen, Jian Wang & Xiubao Ren. (2018) New Insights into Tumor-Infiltrating B Lymphocytes in Breast Cancer: Clinical Impacts and Regulatory Mechanisms. Frontiers in Immunology 9.
Crossref
Crossref
Andreas Ziebart, Ulrich Huber, Sandra Jeske, Simon Laban, Johannes Doescher, Thomas K. Hoffmann, Cornelia Brunner, Edwin K. Jackson & Patrick J. Schuler. (2017) The influence of chemotherapy on adenosine-producing B cells in patients with head and neck squamous cell carcinoma. Oncotarget 9:5, pages 5834-5847.
Crossref
Crossref
Stefan B. Eichmüller, Wolfram Osen, Ofer Mandelboim & Barbara Seliger. (2017) Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape. JNCI: Journal of the National Cancer Institute 109:10.
Crossref
Crossref
Yang Lu, Fanjie Meng, Yang Yang, Lan Li, Donghao Wang, Yuantao Cui, Shangwen Dong & Wanhua Wang. (2017) Significance of B10 cell in patients with thymoma complicated with myasthenia gravis. Oncotarget 8:43, pages 73774-73786.
Crossref
Crossref
Zhigang Zhang, Ying Zhu, Zhen Wang, Ting Zhang, Pin Wu & Jian Huang. (2017) Yin-yang effect of tumor infiltrating B cells in breast cancer: From mechanism to immunotherapy. Cancer Letters 393, pages 1-7.
Crossref
Crossref
Nicole J. Flynn, Rajasekharan Somasundaram, Kimberly M. Arnold & Jennifer Sims-Mourtada. (2017) The Multifaceted Roles of B Cells in Solid Tumors: Emerging Treatment Opportunities. Targeted Oncology 12:2, pages 139-152.
Crossref
Crossref
Wuzhen Chen, Jingxin Jiang, Wenjie Xia & Jian Huang. (2017) Tumor-Related Exosomes Contribute to Tumor-Promoting Microenvironment: An Immunological Perspective. Journal of Immunology Research 2017, pages 1-10.
Crossref
Crossref
Honggeng Guan, Yuqiu Wan, Jing Lan, Qin Wang, Zhangyu Wang, Yecheng Li, Jiqing Zheng, Xueguang Zhang, Zemin Wang, Yueping Shen & Fang Xie. (2016) PD-L1 is a critical mediator of regulatory B cells and T cells in invasive breast cancer. Scientific Reports 6:1.
Crossref
Crossref